Balyasny Asset Management’s BioNTech BNTX Stock Holding History

Balyasny Asset Management’s Portfolio BNTX Stock Details BNTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.17M	Buy	13,200 +6,200	+89%	+$637K	﹤0.01%	2019
2025 Q4	$666K	Buy	+7,000	New	+$705K	﹤0.01%	2384
2025 Q2	–	Sell	-4,400	Closed	-$401K	–	2847
2025 Q1	$401K	Buy	+4,400	New	+$493K	﹤0.01%	2349
2024 Q4	–	Sell	-301,300	Closed	-$35.8M	–	2757
2024 Q3	$35.8M	Buy	+301,300	New	+$27.7M	0.06%	419
2023 Q4	–	Sell	-130,000	Closed	-$14.1M	–	2508
2023 Q3	$14.1M	Sell	130,000 -65,000	-33%	-$7.19M	0.03%	710
2023 Q2	$21M	Buy	+195,000	New	+$21.9M	0.05%	510
2020 Q4	–	Sell	-180,000	Closed	-$12.5M	–	1342
2020 Q3	$12.5M	Buy	180,000 +70,000	+64%	+$5.02M	0.09%	327
2020 Q2	$7.34M	Buy	+110,000	New	+$5.49M	0.06%	414

Other funds holding BNTX

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Flossbach Von Storch Cologne, Germany $21.4B AUM 8.31% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Balyasny Asset Management's BNTX Position: Q1 2026 in Review

Balyasny Asset Management increased its BioNTech (BNTX) stake by 2,639% in Q1 2026, buying an estimated $9.25M and bringing the position to 93,455 shares worth $8.31M. The position accounts for 0.01% of the portfolio, ranked #1118.

Balyasny Asset Management first reported a position in BNTX in Q2 2020 and has held it in 15 quarters since. The position peaked at $73.7M in Q3 2024. 272 funds tracked by Wall St. Rank hold BNTX as of Q1 2026.

Balyasny Asset Management held 93,455 shares of BioNTech worth $8.31M as of Q1 2026.
Balyasny Asset Management bought 90,043 BioNTech shares in Q1 2026, an estimated $9.25M.
BioNTech made up 0.01% of Balyasny Asset Management's portfolio in Q1 2026, its #1118 holding.
Balyasny Asset Management first reported a position in BioNTech in Q2 2020 and has held it in 15 quarters since.
Balyasny Asset Management's BioNTech position peaked at $73.7M in Q3 2024.
272 funds tracked by Wall St. Rank held BioNTech as of Q1 2026.

Based on Balyasny Asset Management's 13F filing for Q1 2026, filed 15 May 2026.